Table 3.
Assessment | Screen | RT | Time, mo |
|||||
---|---|---|---|---|---|---|---|---|
3 | 6 | 12 | 18 | 24 | 36 | |||
Procedure | X | |||||||
Informed consent | X | |||||||
Consult | X | |||||||
Medications | X | X | X | X | X | X | X | |
Adverse events | X | Once | X | X | X | X | X | X |
QOL EPIC | X | X | X | X | X | X | X | |
IPSS | X | X | X | X | X | X | X | |
Laboratory | ||||||||
PSA | X | X | X | X | X | X | X | |
Radiation | 5 txs | |||||||
Tumor | ||||||||
Tumor biopsy | X | |||||||
MRI pelvis (planning) | X | |||||||
Fiducial markers (guidance) | X | Daily | ||||||
Rectal balloon | Daily |
Abbreviations: EPIC, Expanded Prostate Cancer Index Composite; IPSS, International Prostate Symptom Score; MRI, magnetic resonance imaging; PSA, prostate-specific antigen; QOL, quality of life; RT, radiation therapy; txs, treatments.